Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Metformin in Head and Neck Squamous Cell Cancer
NCT02083692Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in head and neck squamous cell carcinoma (HNSCC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Change in TOMM20 and MCT4 expression from tumor cells. Started Sep 2013; status: completed.
02
Drugs
metformin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02083692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083692.